Cyclophosphamide (CYP) is an alkylating agent indicated to treat many forms of cancer and autoimmune diseases, but hemorrhagic cystitis is a frequent side effect of CYP, occurring in 10 to 40% of patients receiving CYP due to the renal excretion of drug metabolites, particularly acrolein [3]. Here, PPIG is linked to cancer.